The signing on behalf of the European Union of the Agreement, in the form of an Exchange of Letters, amending and supplementing the Agreement for scientific and technological cooperation between the European Union and Hashemite Kingdom of Jordan setting out the terms and conditions for the participation of the Hashemite Kingdom of Jordan in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) (‘the Agreement’), is hereby authorised, subject to the conclusion of the said Agreement ( 7 ) .
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
Council Decision (EU) 2024/2875 of 5 November 2024 on the signing, on behalf of the European Union, of the Agreement, in the form of an Exchange of Letters, amending and supplementing the Agreement for scientific and technological cooperation between the European Union and the Hashemite Kingdom of Jordan, setting out the terms and conditions for the participation of the Hashemite Kingdom of Jordan in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA)
The Commission shall ensure the signing of the Agreement, subject to its conclusion.
This Decision shall enter into force on the date of its adoption.
Cite this act
Council Decision (EU) 2024/2875 of 5 November 2024 on the signing, on behalf of the European Union, of the Agreement, in the form of an Exchange of Letters, amending and supplementing the Agreement for scientific and technological cooperation between the European Union and the Hashemite Kingdom of Jordan, setting out the terms and conditions for the participation of the Hashemite Kingdom of Jordan in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32024D2875
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com